Session Details
[O19]Oral Presentation 19
Sun. Sep 27, 2026 1:00 PM - 1:50 PM JST
Sun. Sep 27, 2026 4:00 AM - 4:50 AM UTC
Sun. Sep 27, 2026 4:00 AM - 4:50 AM UTC
Room 6(2F Conference Room 201)
Chair:Chiyomi Sakamoto, Kanako Watanabe
[O19-01]破傷風抗体測定ELISAの性能評価とヒト由来試料への適用性
*Chiyomi Sakamoto1,2, Kohsuke Kumeda1,3, Chie Shitada1,2, Susumu Yamaori3, Motohide Takahashi1,2 (1. Kumamoto health science university Toxin and Biologicals Research Laboratory, 2. The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), 3. KM Biologics Co., Ltd.)
[O19-02]アルパカ由来三価VHHによる破傷風神経毒素の完全中和能と受動免疫への応用
*Chiyomi Sakamoto1,2, Chie Shitada1,2, Nobuo Miyazaki3, Norihiko Kiyose3, Sena Kamesawa4, Hiroshi Morioka4, Kazunori Morokuma5, Kazuhiko Tomokiyo2, Motohide Takahashi1,2 (1. Kumamoto Health science university Toxin and Biologicals Research Laboratory, 2. The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), 3. ARK Resource Co., Ltd., 4. Graduate School of Pharmaceutical Sciences, Kumamoto University, 5. KM Biologics Co., Ltd.,)
[O19-03]生物学的製剤等の製造所におけるバイオセーフティに関する新指針案の策定
*Osamu Kawamata1,10, Motohide Takahashi2, Tsuguo Sasaki3, Takeru Urayama4, Kimiyuki Yamada5, Kazuhito Tanimoto6, Yasuhito Ikematsu7, Manabu Mizutani3, Masaji Suzuki8, Ryoko Naruse9, Shingou Sakurai1, Osamu Hiruta2 (1. Tokyo University of Science, 2. Kumamoto Health Science University, 3. The University of Osaka, 4. Japan Blood Products Organization, 5. Takeda Pharmaceutical Company Limited, 6. Shibuya Corporation, 7. Hitachi, Ltd., 8. PDA Japan Chapter, 9. Toyama Prefectural University, 10. Tokyo University of Agriculture and Technology)
[O19-04]ウイルス検査技術連絡会の精度管理に関する活動報告
*Reika Noyama1, Ema Saito1, Takaaki Kawasima1, Junko takada1, Koichi Motoe1, Miho Himeno1, Toshihiko Okuhara1, Yui Ishikura1, Hideki Terao1, Nobuhusa Sato1, Makoto Yamazaki1 (1. Virus Testing Technology Liaison Committee)
[O19-05]医学部学生を対象とした予防接種e-learning教材の構築と評価
*Yuka Sakata1, Hajime Kamiya1, Ai Hanasaki2, Mizue Kanai1, Kuurdor Elijah1, Shinji Matsumoto1, Mai Okuyama3, Masamitsu Takamatsu3, Tomohiro Katsuta4, Megumi Kubota5, Aya Saito6, Tatsuki Ikuse7, Manami Nakashita8, Kazutoshi Nakashima9, Takashi Nakano1,10 (1. Department of Public Health, Occupational Medicine, and Applied Epidemiology, Graduate School of Medicine, Mie University, 2. Medical Education and Nursing Education Center, Faculty of Medicine, Mie University, 3. Department of Vaccinology, National Institute of Infectious Diseases, Japan Institute for Health Security (JIHS), 4. Department of Pediatrics, St. Marianna University School of Medicine, 5. Kubota Children's Clinic, 6. Division of Nursing, Graduate School of Health Sciences, Niigata Universityd, 7. Department of Infectious Diseases, Tokyo Metropolitan Children’s Medical Center, 8. Laboratory of Social Pharmacy and Epidemiology, Showa Pharmaceutical University, 9. Department of Health Science, Faculty of Sports and Health Science, Daito Bunka University, 10. Department of Pediatrics, Kawasaki Medical School)
